Top Markets
#1 Useless Coin Useless Coin +39.98%
#2 StonkBroker StonkBroker +38.07%
#3 Merlin's Seal BTC Merlin's Seal BTC +37.69%
#4 0G 0G +34.77%
#5 SAFEcoin SAFEcoin +30.08%
#6 Dogs Dogs +19.32%
#7 Arbitrum Arbitrum +18.58%
#8 Full Moon Full Moon +17.84%
#9 Zora Zora +17.77%
#10 Notcoin Notcoin +17.21%
Coin of the day
Useless Coin Useless Coin
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Relmada Therapeutics, Inc. Relmada Therapeutics, Inc.

Relmada Therapeutics, Inc.

RLMD
Classement en actions #13823
Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company... Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company in the United States. The company focuses on the development of NDV-01, a controlled-release intravesical formulation of gemcitabine and docetaxel, which is in Phase 2 clinical trial for patients with aggressive forms of non-muscle invasive bladder cancer; and Sepranolone, a neurosteroid epimer of allopregnanolone, which is Phase 2b-ready for the potential treatment of prader-willi syndrome, tourette syndrome, excessive tremor, and other diseases related to excessive GABAergic activity. The company has an agreement with Asarina Pharma AB and Trigone. Relmada Therapeutics, Inc. was founded in 2004 and is headquartered in Coral Gables, Florida.
Prix de l'action
$4.36
Capitalisation boursière
$457.32M
Changement (1 jour)
0.69%
Changement (1 an)
289.29%
Pays
US
Échange Relmada Therapeutics, Inc. (RLMD)

Catégorie

Healthcare
Le prix RLMD avec la capitalisation boursière de B
Relmada Therapeutics, Inc. Relmada Therapeutics, Inc.
RLMD
$4.36
Capitalisation boursière de Relmada Therapeutics, Inc.(RLMD)
Capitalisation boursière: $457.32M
En August 2026, Relmada Therapeutics, Inc. a une capitalisation boursière de $457.32M. Cela fait de Relmada Therapeutics, Inc. la 13823rd entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Relmada Therapeutics, Inc. du 2014 au 2026
RLMD par rapport au top 5 des plus populaires stocks
Prix pour RLMD L’actif B La capitalisation boursière de B Résultats
Relmada Therapeutics, Inc. Relmada Therapeutics, Inc.
$50,784.67 $457.32M
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.327T +1,164,685.90%
Relmada Therapeutics, Inc. Relmada Therapeutics, Inc.
$44,283.31 $457.32M
Apple Inc. Apple Inc.
AAPL
$4.645T +1,015,572.25%
Relmada Therapeutics, Inc. Relmada Therapeutics, Inc.
$38,805.04 $457.32M
Alphabet Inc. Alphabet Inc.
GOOG
$4.070T +889,923.79%
Relmada Therapeutics, Inc. Relmada Therapeutics, Inc.
$36,081.42 $457.32M
Microsoft Corporation Microsoft Corporation
MSFT
$3.785T +827,455.52%
Relmada Therapeutics, Inc. Relmada Therapeutics, Inc.
$26,600.47 $457.32M
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.790T +610,002.42%